Kai Risdahl

They're also very expensive and not universally covered by employer health insurance.

Only about half of big companies do, far, far fewer small and mid-sized companies.

So Eli Lilly, purveyor of ZepBound, is trying something new, as Marketplace's Nova Safo reports.

Honestly, I don't even know what to do with that.

But first, let's do the numbers.

Dow Industrials down 453, about 1%, 47,501.

The Nasdaq off 361, that is 1.6%, 22,387.

S&P 500 down 90 points, 1.3%, 6740.

The wah-wahs indeed.

However, comma...

For the week, the five days gone by, the Dow gave up 3%, the Nasdaq down 1%, and a quarter percent S&P 500 slipped 2%.

Clothing retailers shared the pain today.

Winter quarter at the Gap wasn't so great.

That includes their brands Old Navy, Banana Republic, and Athleta.

The Gap tanked 14.4% today.

Rival Abercrombie & Fitch declined 3.8%.

Novo was just talking about Eli Lilly.

Both Lilly and its rival Norvo Nordisk have been cutting prices of their GLP-1 drugs for customers who pay out of pocket.

Indiana-based Eli Lilly inched up 7 tenths percent.

The Danish Norvo Nordisk contracted 1.25 percent.